HLscience Co., Ltd.

₩5,750As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:239610Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (14.85%)
Div yield —
ROE (13.36%)
Pharmaceutical Preparations
Beta (5Y) 0.74
PE TTM —
TSR TTM (35.83%)
Mkt cap ₩29.28B
ROIC (18.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,633
15.35%
(33.83%)
Hold 7|12|10|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
114.61
110.75
122.19
130.34
21.41%
14.19%
16.24%
20.41%
Revenue₩B
1.913
2.017
2.099
2.147
(1.73%)
6.35%
10.96%
15.64%
Peers (US$21.59M)
Cap (US$)
PE
22.37M
20.31x
Capital
TTM
5Y
10Y
Leveragex
0.809
(0.039)
(0.030)
EBIT/Intx
1.888
3.312
3.379
Own earn%
(112.56)
(45.40)
(37.08)
Sh yield%
40.42
43.42
40.02
Owners
Insiders/Inst%
2.38
77.95
Short interest%
0.71
SBC / revenue%
1.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
25–29
$1 testx
—
Incr. ROIC%
6